跳至主要内容
MedPath Trial logoMedPath TrialMedPath Trial Home
临床试验/PER-036-03
PER-036-03已完成1 期

COMPARATIVE STUDY OF PHASE 3, RANDOMIZED, DOUBLE BLIND MICAFUNGIN (FK463) VERSUS FLUCONAZOL FOR THE TREATMENT OF CANDIDIASIS ESOFAGITIS

FUJISAWA HEALTH CARE INC,0 个研究点目标入组 0 人开始时间: 2003年7月14日最近更新:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
适应症

试验速览

阶段
1 期
状态
已完成
发起方
研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
0 至 0（—）

入选标准

  • •Diagnosis of esophageal candidiasis confirmed by endoscopy
  • •Negative pregnancy test in females of childbearing potential

排除标准

  • •Pregnant or nursing
  • •Evidence of liver disease
  • •Presence of another active opportunistic fungal infection and/or receiving acute systemic therapy for an opportunistic fungal infection
  • •Concomitant esophagitis caused by herpes simplex virus or cytomegalovirus
  • •Receipt of an oral or topical antifungal agent within 48 hours or a systemic agent within 72 hours of first dose of study drug
  • •Non-responsive to therapy in any prior systemic antifungal clinical trail
  • •History of > 2 episodes of esophageal candidiasis requiring systemic antifungal therapy
  • •History of anaphylaxis attributed to azole compounds or echinocandin class of antifungals

研究者

发起方
FUJISAWA HEALTH CARE INC,

相似试验

已完成
不适用
Comparative Trial of Micafungin Versus Fluconazole for Treating Esophageal Candidiasis.-B379 Candidiasis, unspecifiedCandidiasis, unspecifiedB379
PER-055-03FUJISAWA HEALTH CARE INC,
已完成
不适用
COMPARATIVE TRIAL OF MICAFUNGIN VERSUS FLUCONAZOLE FOR TREATING ESOPHAGEAL CANDIDIASIS.-B379 Candidiasis, unspecifiedCandidiasis, unspecifiedB379
PER-048-03FUJISAWA HEALTH CARE INC,
已完成
不适用
Trial of Two Dosing Regimens of Micafungin Versus Caspofungin for the Treatment of Esophageal Candidiasis-B37 CandidiasisB37Candidiasis
PER-023-04FUJISAWA HEALTH CARE INC,
已完成
不适用
Trial of Two Dosing Regimens of Micafungin Versus Caspofungin for the Treatment of Esophageal CandidiasisCandidiasis-B37 CandidiasisB37
PER-026-04FUJISAWA HEALTH CARE INC,
已完成
不适用
Trial of Two Dosing Regimens of Micafungin Versus Caspofungin for the Treatment of Esophageal Candidiasis-B379 Candidiasis, unspecifiedCandidiasis, unspecifiedB379
PER-024-04FUJISAWA HEALTH CARE INC,